journal article·2016-06Open access

Insight into membrane selectivity of linear and branched polyethylenimines and their potential as biocides for advanced wound dressings

Stephen John Fox, Mobashar Hussain Urf Turabe Fazil, Chetna Dhand, Mayandi Venkatesh, Eunice Tze Leng Goh, Sriram Harini, Christo Eugene, Rayne Rui Lim, Seeram Ramakrishna, Shyam Sunder Chaurasia, Roger W. Beuerman, Chandra Shekhar Verma, Navin Kumar Verma, Xian Jun Loh, Rajamani Lakshminarayanan

Acta Biomaterialia· Volume 37

Abstract

Unlabelled We report here structure-property relationship between linear and branched polyethylene imines by examining their antimicrobial activities against wide range of pathogens. Both the polymers target the cytoplasmic membrane of bacteria and yeasts, eliciting rapid microbicidal properties. Using multiscale molecular dynamic simulations, we showed that, in both fully or partially protonated forms LPEI discriminates between mammalian and bacterial model membranes whereas BPEI lacks selectivity for both the model membranes. Simulation results suggest that LPEI forms weak complex with the zwitterionic lipids whereas the side chain amino groups of BPEI sequester the zwitterionic lipids by forming tight complex. Consistent with these observations, label-free cell impedance measurements, cell viability assays and high content analysis indicate that BPEI is cytotoxic to human epithelial and fibroblasts cells. Crosslinking of BPEI onto electrospun gelatin mats attenuate the cytotoxicity for fibroblasts while retaining the antimicrobial activity against Gram-positive and yeasts strains. PEI crosslinked gelatin mats elicit bactericidal activity by contact-mediated killing and durable to leaching for 7days. The potent antimicrobial activity combined with enhanced selectivity of the crosslinked ES gelatin mats would expand the arsenel of biocides in the management of superficial skin infections. The contact-mediated microbicidal properties may avert antimicrobial resistance and expand the diversity of applications to prevent microbial contamination. Statement of significance Current commercially available advanced wound dressings are either impregnated with metallic silver or silver salts which have side effects or may not avert antimicrobial resistance. In this article, we have used multidisciplinary approach comprising of computational, chemical and biological methods to understand the antimicrobial properties and biocompatibility of linear (LPEI) and branched (BPEI) polyethylenimines. We then applied this knowledge to develop dual purpose wound dressings containing these polymers, which encourages healing while maintain antimicrobial activity. In addition, the approach can be expanded to rationalize the antimicrobial vs. cytotoxicity of other cationic polymers and the method of crosslinking would enhance their potentials as biocides for advanced materials.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Antimicrobial agents and applications · Wound Healing and Treatments · Advanced Polymer Synthesis and Characterization

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (71)

Show source-provided references
1. The evolving threat of antimicrobial resistance · 2012
2. European Centre for Disease Prevention and Control (ECDC) and European Medicines Agency (EMEA) · 2012
3. Estimates of Healthcare-Associated Infections, August 2010, accessed: August, (2010).
4. Combating antimicrobial resistance: policy recommendations to save lives10.1093/cid/cir153 ↗
5. Douglas Scott · 2009
6. Infections in burns10.1097/TA.0b013e318065af1a ↗
7. Recent advances on the development of wound dressings for diabetic foot ulcer treatment—a review10.1016/j.actbio.2013.03.033 ↗
8. Wound microbiology and associated approaches to wound management10.1128/CMR.14.2.244-269.2001 ↗
9. Emerging infections in burns10.1089/sur.2009.024 ↗
10. Clinical presentations of soft-tissue infections and surgical site infections10.1086/321862 ↗
11. Polymicrobial nature of chronic diabetic foot ulcer biofilm infections determined using bacterial tag encoded FLX amplicon pyrosequencing (bTEFAP)10.1371/journal.pone.0003326 ↗
12. Skin, soft tissue, bone, and joint infections in hospitalized patients: epidemiology and microbiological, clinical, and economic outcomes10.1086/520743 ↗
13. Skin and skin structure infections: treatment with newer generation fluoroquinolones10.2147/tcrm.2007.3.2.309 ↗
14. Topical antimicrobials for burn wound infections10.2174/157489110791233522 ↗
15. Topical antimicrobial therapy for treating chronic wounds10.1086/644732 ↗
16. Impact of silver-containing wound dressings on bacterial biofilm viability and susceptibility to antibiotics during prolonged treatment10.1128/AAC.00825-10 ↗
17. An in vitro study of antimicrobial activity and efficacy of iodine-generating hydrogel dressings10.12968/jowc.2006.15.7.26929 ↗
18. In vitro efficacy of a polyhexamethylene biguanide-impregnated gauze dressing against bacteria found in veterinary patients10.1111/j.1532-950X.2004.04059.x ↗
19. Best Practice Statement · 2010
20. Targeting bacterial membrane function: an underexploited mechanism for treating persistent infections10.1038/nrmicro2474 ↗
21. Quaternary ammonium biocides: efficacy in application10.1128/AEM.02633-14 ↗
22. Colistin: an update on the antibiotic of the 21st century10.1586/eri.12.78 ↗
23. Ceragenins (cationic steroid compounds), a novel class of antimicrobial agents10.1358/dnp.2008.21.6.1246829 ↗
24. Structures of the dimeric and monomeric variants of magainin antimicrobial peptides (MSI-78 and MSI-594) in micelles and bilayers, determined by NMR spectroscopy10.1021/bi0601813 ↗
25. Design and synthesis of amphiphilic xanthone-based, membrane-targeting antimicrobials with improved membrane selectivity10.1021/jm301683j ↗
26. Safe and efficient membrane permeabilizing polymers based on PLLA for antibacterial applications10.1039/C6RA04531F ↗
27. Layer-by-layer assemblies for antibacterial applications10.1039/C5BM00307E ↗
28. Polycation cytotoxicity: a delicate matter for nucleic acid therapy—focus on polyethylenimine10.1039/c000190b ↗
29. Polyethylenimine is a strong inhibitor of human papillomavirus and cytomegalovirus infection10.1128/AAC.05147-11 ↗
30. Antibacterial activity of bone cement containing quaternary ammonium polyethyleneimine nanoparticles10.1093/jac/dkt441 ↗
31. Polyethyleneimine nanoparticles incorporated into resin composite cause cell death and trigger biofilm stress in vivo10.1073/pnas.1010341107 ↗
32. Permanently microbicidal materials coatings10.1039/b702079a ↗
33. Studies on the preparation and antibacterial properties of quaternized polyethyleneimine10.1163/156856207780852523 ↗
34. Poly (ethylene imine)s as antimicrobial agents with selective activity10.1002/mabi.201200052 ↗
35. Poly (ethyleneimines) in dermal applications: biocompatibility and antimicrobial effects10.1016/j.ijpharm.2013.08.001 ↗
36. Premarket approval application (PMA) for the Adherus® AutoSpray Dural Sealant, (2013).
37. The Effects of a Polyethyleneimine-coated Membrane (oXiris™) for Hemofiltration Versus Polymyxin B-Immobilized Fibre Column (Toraymyxin™) for Hemoperfusion on Endotoxin Activity and Inflammatory Conditions in Septic Shock-A Randomized Controlled Pilot Study (ENDoX-study), (2015).
38. CHARMM-GUI: a web-based graphical user interface for CHARMM10.1002/jcc.20945 ↗
39. CHARMM-GUI membrane builder toward realistic biological membrane simulations10.1002/jcc.23702 ↗
40. CHARMM-GUI membrane builder for mixed bilayers and its application to yeast membranes10.1016/j.bpj.2009.04.013 ↗
41. The amber biomolecular simulation programs10.1002/jcc.20290 ↗
42. An overview of the amber simulation package10.1002/wcms.1121 ↗
43. Lipid14: the amber lipid force field10.1021/ct4010307 ↗
44. Development and testing of a general amber force field10.1002/jcc.20035 ↗
45. NWChem: a comprehensive and scalable open-source solution for large scale molecular simulations10.1016/j.cpc.2010.04.018 ↗
46. Autophagy induction by silver nanowires: a new aspect in the biocompatibility assessment of nanocomposite thin films10.1016/j.taap.2012.08.023 ↗
47. Similarities and differences in the responses of microorganisms to biocides10.1093/jac/dkg422 ↗
48. Phosphatidylethanolamine-phosphatidylglycerol bilayer as a model of the inner bacterial membrane10.1529/biophysj.104.048835 ↗
49. The organization of the plasma membrane of mammalian cells: structure in relation to function
50. Gennis · 1989 · 1
51. Insolubility of lipids in triton X-100: physical origin and relationship to sphingolipid/cholesterol membrane domains (rafts)10.1016/S0304-4157(00)00007-1 ↗
52. Cholesterol depletion induces large scale domain segregation in living cell membranes10.1073/pnas.231377398 ↗
53. Cholesterol interactions with phospholipids in membranes10.1016/S0163-7827(01)00020-0 ↗
54. Structure and function of sphingolipid- and cholesterol-rich membrane rafts10.1074/jbc.R000005200 ↗
55. Correlation of daptomycin bactericidal activity and membrane depolarization in Staphylococcus aureus10.1128/AAC.47.8.2538-2544.2003 ↗
56. Improved antimicrobial peptides based on acyl-lysine oligomers10.1038/nbt1309 ↗
57. Synthetic multivalent antifungal peptides effective against fungi10.1371/journal.pone.0087730 ↗
58. Antibacterial action of structurally diverse cationic peptides on gram-positive bacteria10.1128/AAC.44.8.2086-2092.2000 ↗
59. Ramoplanin at bactericidal concentrations induces bacterial membrane depolarization in Staphylococcus aureus10.1128/AAC.00061-14 ↗
60. High content analysis of the biocompatibility of nickel nanowires10.1016/j.jmmm.2009.02.035 ↗
61. Determination of spiropyran cytotoxicity by high content screening and analysis for safe application in bionanosensing10.1021/tx100123g ↗
62. Cytotoxicity evaluation of nanoclays in human epithelial cell line A549 using high content screening and real-time impedance analysis10.1007/s11051-012-1137-5 ↗
63. Breaking up the correlation between efficacy and toxicity for nonviral gene delivery10.1073/pnas.0703882104 ↗
64. Gene delivery through the use of a hyaluronate-associated intracellularly degradable crosslinked polyethyleneimine10.1016/j.biomaterials.2009.07.012 ↗
65. Mussel-inspired one-pot synthesis of a fluorescent and water-soluble polydopamine–polyethyleneimine copolymer10.1002/marc.201500021 ↗
66. Vibrational assignments for high molecular weight linear polyethylenimine (LPEI) based on monomeric and tetrameric model compounds10.1021/ma030016k ↗
67. Characterization of polydopamine thin films deposited at short times by autoxidation of dopamine10.1021/la400587j ↗
68. Clinical and Laboratory Standard Institute (CLSI) · 2008
69. Standardizing an in vitro procedure for the evaluation of the antimicrobial activity of wound dressings and the assessment of three wound dressings10.1093/jac/dks110 ↗
70. Quantifying bacterial bioburden during negative pressure wound therapy: does the wound VAC enhance bacterial clearance?10.1097/01.sap.0000111861.75927.4d ↗
71. Multi-functional fluorescent carbon dots with antibacterial and gene delivery properties10.1039/C5RA07968C ↗